Pricing Log in Create free account

Apnimed, Inc. (APMD) vs Obsidian Therapeutics, Inc (OBX)

Apnimed, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Apnimed, Inc. and Obsidian Therapeutics, Inc are of similar size ($593.0M and $589.5M). Across the 5 metrics below, Apnimed, Inc. leads on 3 and Obsidian Therapeutics, Inc on 2.

Valuation

Metric APMD OBX Biotechnology median
P/E 0.76 — 10.60
P/S 0.62 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales (0.18) n/m 9.02
Earnings yield 130.86% — (32.88%)
Free cash flow yield (115.77%) 0.00% (23.13%)

Profitability

Metric APMD OBX Biotechnology median
Gross margin 94.53% — 68.51%
Operating margin 19.88% — 0.00%
Net margin 81.56% — 0.00%
Free cash flow margin (71.50%) — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APMD OBX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (14.69%) (11.60%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric APMD OBX Biotechnology median
Debt to equity (0.45) 0.00 0.00
Current ratio 5.19 4.21 4.97
Net debt to EBITDA 0.02 0.77 1.01

Dividend

Metric APMD OBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APMD OBX Biotechnology median
Market cap 589.49m 593.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack